Stephan-Georg Mueller

Title: The Innovations of Stephan-Georg Mueller

Introduction

Stephan-Georg Mueller is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of new compounds. His work focuses on compounds that possess valuable pharmacological activity, which can have a profound impact on medical treatments.

Latest Patents

Mueller holds a patent for his invention titled "6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them." This patent describes compounds defined by a specific formula, which are agonists of the 5-HT2C receptor. These compounds are particularly relevant for the treatment and prevention of diseases influenced by the inhibition of this receptor, including metabolic and CNS-related disorders. He has 1 patent to his name.

Career Highlights

Stephan-Georg Mueller is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to contribute to the development of innovative therapeutic solutions. His research has been instrumental in advancing the understanding of pharmacological compounds and their applications in medicine.

Collaborations

Throughout his career, Mueller has collaborated with several talented individuals, including Christopher John Brown and Alexander Heifetz. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Stephan-Georg Mueller's contributions to pharmaceutical innovations highlight the importance of research and development in creating effective medical treatments. His work continues to influence the field and offers promising solutions for various health-related challenges.